IL15 and neoplasm: Notably, tumor targeting was achieved and shown relevant for the treatment efficacy of bifunctional antibody-fusion proteins with all three cytokines (IL-15, IL-21 and IL-7) in immunocompetent mouse models (25, 28–31).